Hungarian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

xanthine/rák

A hivatkozás a vágólapra kerül
Oldal 1 tól től 17 eredmények

Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND 1. Field of the Invention The present invention relates to a metabolite of a xanthine Phosphodiesterase type 5 ("PDE 5") inhibitor useful for treatment of erectile dysfunction, and derivatives, formulations and processes related thereto. 2. Background U.S. patent application Ser. No.

Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION Over half of all new cancers are skin cancers and its incidence is on the rise due to increased recreational exposure to sunlight and depletion of the ozone layer (American Cancer Society's 2004 Facts & Figures; Nataraj, et al. (1995) Photochem. Photobiol. 62:218-230;

Agent for overcoming resistance to anti-cancer agent

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
TECHNICAL FIELD The present invention relates to an agent containing a xanthine oxidase inhibitor as an active ingredient for overcoming anti-cancer agent resistance. PRIOR ART Chemotherapy is indispensable for cancer treatment. On the other hand, cancer often develops resistance to chemotherapy.

Method of inhibiting the activity of leukocyte derived cytokines

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate

Method of inhibiting the activity of leukocyte derived cytokines

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate

Method of inhibiting the activity of leukocyte derived cytokines

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION The invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate

Method of inhibiting the activity of leukocyte derived cytokines

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate

Method of inhibiting the activity of leukocyte derived cytokines

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION This invention relates to the inhibition of activity of leukocyte derived cytokines, such as interleukin-1 and tumor necrosis factor, in humans and mammals. More specifically, this invention provides a method of inhibiting the activity of cytokines to arrest or alleviate

Use of cocoa polyphenols for treating a prostate hyperplasia, a specific cocoa extract and applications

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
The present invention relates to the use of cocoa polyphenols for treating prostate hyperplasia, to a specific cocoa extract and to the uses of said extract in the pharmaceutical and food sectors. The invention more specifically relates to the use of cocoa polyphenols for preventively or curatively

Pyrazole derivative

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2014/059912 filed Mar. 28, 2014, claiming priority based on Japanese Patent Application No. 2013-072788 filed Mar. 29, 2013, the contents of all of which are incorporated herein by

Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF THE INVENTION The invention pertains to methods of administering active agents to inhibit unwanted bone resorption, and pharmaceutical compositions and articles containing such active agents. BACKGROUND OF THE INVENTION The unwanted loosening of orthopaedic implants of all types, including

Pharmaceutical containing TNF inhibitor

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION It is known that the definition of the term tumor necrosis factor (TNF) includes two cytotoxic factors (TNF- .alpha. and TNF-.beta.) which are essentially formed by activated lymphocytes and monocytes. The term TNF derives from the property which initially attracted

Azole benzene derivative

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2014/052154 filed Jan. 30, 2014, claiming priority based on Japanese Patent Application No. 2013-017167 filed Jan. 31, 2013, the contents of all of which are incorporated herein by

Tumorigenesis inhibitor

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This application is a U.S. national stage of International Application No. PCT/JP2004/003315 filed Mar. 12, 2004. TECHNICAL FIELD The present invention relates to a novel agent for suppressing tumorigenesis. BACKGROUND ART As a therapeutic drug for gout and hyperuricemia, allopurinol having a

Antitumor agents

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND OF THE INVENTION (a) Field of the Invention The present invention relates to a group of antitumor agents which by themselves are not toxic and exhibit an improved tumor selective cytotoxic action due to their preferential accumulation in tumor tissue only after subsequent administration
Csatlakozzon
facebook oldalunkhoz

A legteljesebb gyógynövény-adatbázis, amelyet a tudomány támogat

  • Működik 55 nyelven
  • A tudomány által támogatott gyógynövényes kúrák
  • Gyógynövények felismerése kép alapján
  • Interaktív GPS térkép - jelölje meg a gyógynövényeket a helyszínen (hamarosan)
  • Olvassa el a keresésével kapcsolatos tudományos publikációkat
  • Keresse meg a gyógynövényeket hatásuk szerint
  • Szervezze meg érdeklődését, és naprakész legyen a hírkutatással, a klinikai vizsgálatokkal és a szabadalmakkal

Írjon be egy tünetet vagy betegséget, és olvassa el azokat a gyógynövényeket, amelyek segíthetnek, beírhat egy gyógynövényt, és megtekintheti azokat a betegségeket és tüneteket, amelyek ellen használják.
* Minden információ publikált tudományos kutatáson alapul

Google Play badgeApp Store badge